Pioglitazone abrogates cyclosporine-evoked hypertension via rectifying abnormalities in vascular endothelial function.
about
Additive Renoprotection by Pioglitazone and Fenofibrate against Inflammatory, Oxidative and Apoptotic Manifestations of Cisplatin Nephrotoxicity: Modulation by PPARsPI3K/Akt-independent NOS/HO activation accounts for the facilitatory effect of nicotine on acetylcholine renal vasodilations: modulation by ovarian hormonesEnhanced catabolism to acetaldehyde in rostral ventrolateral medullary neurons accounts for the pressor effect of ethanol in spontaneously hypertensive rats.Endothelin ETA receptor/lipid peroxides/COX-2/TGF-β1 signalling underlies aggravated nephrotoxicity caused by cyclosporine plus indomethacin in ratsRole of rostral ventrolateral medullary ERK/JNK/p38 MAPK signaling in the pressor effects of ethanol and its oxidative product acetaldehyde.The inflammatory state provokes sexual dimorphism in left ventricular and electrocardiographic effects of chronic cyclosporine in rats.Central modulation of cyclosporine-induced hypertension.Protective effect of curcumin on cyclosporin A-induced endothelial dysfunction, antioxidant capacity, and oxidative damage.Pioglitazone enhances the blood pressure-lowering effect of losartan via synergistic attenuation of angiotensin II-induced vasoconstriction.Chrysin and luteolin attenuate diabetes-induced impairment in endothelial-dependent relaxation: effect on lipid profile, AGEs and NO generation.Rosiglitazone, a peroxisome proliferator-activated receptor γ stimulant, abrogates diabetes-evoked hypertension by rectifying abnormalities in vascular reactivity.
P2860
Q28550672-3A25163A-67E9-4844-B536-336C083C18EEQ35148122-45B402A2-1388-4232-BB3A-9DF8B808B5ABQ35964939-1A6B5A39-28A6-4E09-8F39-F5B1F6D67DCCQ36016411-30DD5380-B860-4E52-A716-E9FF1C1F9612Q37265967-ABB34D6A-94E6-4277-AEDA-2D6D90C9CAF8Q37637979-E19966AF-9216-4F7A-A603-3FE9E3E31211Q38272109-A9631FAE-F9E2-47E6-8EC7-23D1DEC7DEADQ45272269-9EA986B3-8487-4B66-BA11-773080F1CD00Q45839734-926F9CD0-AA2D-44A3-8CD5-23BA42DE48B0Q46050931-3F4C52BF-EF92-4E6A-BD3C-4B98BC7FD93EQ49180207-ED807652-E8BD-4307-8143-CD2DFE07BBD9
P2860
Pioglitazone abrogates cyclosporine-evoked hypertension via rectifying abnormalities in vascular endothelial function.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Pioglitazone abrogates cyclosp ...... vascular endothelial function.
@en
Pioglitazone abrogates cyclosp ...... vascular endothelial function.
@nl
type
label
Pioglitazone abrogates cyclosp ...... vascular endothelial function.
@en
Pioglitazone abrogates cyclosp ...... vascular endothelial function.
@nl
prefLabel
Pioglitazone abrogates cyclosp ...... vascular endothelial function.
@en
Pioglitazone abrogates cyclosp ...... vascular endothelial function.
@nl
P2093
P2860
P1476
Pioglitazone abrogates cyclosp ...... vascular endothelial function
@en
P2093
Abdel A Abdel-Rahman
Abdel-Galil A Abdel-Galil
Evan I Saad
Khaled S Abd-Elrahman
P2860
P304
P356
10.1016/J.BCP.2010.11.013
P407
P577
2010-11-27T00:00:00Z